Enanta Pharmaceuticals Inc (ENTA) Insider Trading

Total insider buys:
  • $2,977,699.00
Total insider sells:
  • $79,432,036.39
Most recent insider trade:
  • July 15, 2024
Most active insider trader:
  • Paul J Mellett
Trader NameDateTitleAmountPriceTypeTotal Value
July 15, 2024Insider5,375$17.08Sell$91,805.00
July 11, 2024Insider4,299$15.07Sell$64,785.93
June 17, 2024Insider7,266$12.33Sell$89,589.78
Dec. 13, 2023Director15,295$9.12Sell$139,490.40
Dec. 5, 2023CMO534$9.63Sell$5,142.42
Dec. 5, 2023CFO2,412$9.63Sell$23,227.56
Dec. 5, 2023CEO7,230$9.63Sell$69,624.90
Dec. 5, 2023VP2,125$9.63Sell$20,463.75
March 15, 2023CFO10,440$44.43Sell$463,849.20
March 15, 2023VP13,925$44.45Sell$618,966.25
March 13, 2023CEO27,912$45.16Sell$1,260,505.92
Feb. 9, 2023CFO5,000$53.76Sell$268,800.00
Dec. 16, 2022CEO30,000$44.72Sell$1,341,600.00
April 4, 2022VP32,785$72.18Sell$2,366,421.30
April 1, 2022VP50,559$71.23Sell$3,601,317.57
March 21, 2022Director6,000$67.83Sell$406,980.00
March 1, 2022VP24,339$70.26Sell$1,710,058.14
Jan. 11, 2022VP12,536$70.13Sell$879,149.68
Dec. 1, 2021VP13,523$86.35Sell$1,167,711.05
Nov. 1, 2021VP9,547$84.89Sell$810,444.83
Oct. 11, 2021VP4,047$70.34Sell$284,665.98
Oct. 8, 2021VP13,453$70.09Sell$942,920.77
Sept. 15, 2021CEO4,516$59.06Sell$266,714.96
Jan. 8, 2021CFO6,000$45.58Sell$273,480.00
Jan. 2, 2020CFO10,000$60.88Sell$608,800.00
March 11, 2019Director1,546$99.16Sell$153,301.36
March 4, 2019Director9,280$103.65Sell$961,872.00
March 1, 2019VP10,000$103.53Sell$1,035,300.00
Feb. 13, 2019VP3,270$95.28Sell$311,565.60
Feb. 12, 2019Director7,734$90.01Sell$696,137.34
Feb. 11, 2019VP27,684$89.39Sell$2,474,672.76
Oct. 1, 2018Insider25,000$83.64Sell$2,091,000.00
Sept. 20, 2018VP4,155$95.32Sell$396,054.60
Aug. 20, 2018VP4,155$92.32Sell$383,589.60
July 18, 2018VP5,045$124.84Sell$629,817.80
July 6, 2018Insider35,000$125.24Sell$4,383,400.00
June 18, 2018VP4,155$114.85Sell$477,201.75
June 11, 2018Treasurer15,000$120.57Sell$1,808,550.00
May 17, 2018Insider25,000$105.83Sell$2,645,750.00
May 16, 2018VP4,155$105.25Sell$437,313.75
April 16, 2018VP4,225$85.58Sell$361,575.50
March 19, 2018Treasurer9,000$86.48Sell$778,320.00
Jan. 4, 2017Insider13,921$35.09Sell$488,487.89
Nov. 29, 2016Insider13,921$31.44Sell$437,676.24
May 11, 2016VP500$24.45Buy$12,225.00
Feb. 12, 2016Director2,000$27.04Buy$54,080.00
Nov. 24, 2015CFO6,000$30.15Sell$180,900.00
Oct. 15, 2015CFO7,500$40.10Sell$300,750.00
Sept. 8, 2015CFO7,500$39.55Sell$296,625.00
July 13, 2015CFO7,500$46.29Sell$347,175.00
First«1 of 2»Last
  • Insiders are both buying and selling Enanta Pharmaceuticals Inc stock.

  • The insider traders at Enanta Pharmaceuticals Inc are: Nathalie Adda, Paul J Mellett, Yat Sun Or, Jay R Luly, Saints Capital Granite, L.P., Paul J. Mellett, V Life Science Ventures Gm Tvm, Scott T Rottinghaus, Nathaniel S Gardiner, Bruce L A Carter, Jay Luly, Stephen Jr. Buckley, Terry Vance, Brendan Luu, Tara Lynn Kieffer, Helmut Schuhsler, Tim Ocain, George Golumbeski, and Marc E Goldberg

  • The most active insider trader at Enanta Pharmaceuticals Inc is Nathalie Adda with 14 trades.

  • V Life Science Ventures Gm Tvm has sold the most Enanta Pharmaceuticals Inc stock with a total value of $45,514,905.15.

  • Helmut Schuhsler has bought the most Enanta Pharmaceuticals Inc stock with a total value of $3,722,572.00.

  • The most recent insider trade for Enanta Pharmaceuticals Inc was on July 15, 2024.

  • The single biggest insider buy for Enanta Pharmaceuticals Inc was from Helmut Schuhsler with a total value of $1,861,286.00 on March 26, 2013.

  • The single biggest insider sell for Enanta Pharmaceuticals Inc was from V Life Science Ventures Gm Tvm with a total value of $17,054,945.88 on March 4, 2014.